Instadose Pharma Corp.

INSD

US45783B1035

Home Furnishings

Delayed OTC Markets Other stock markets 20:34:47 29/12/2023 GMT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2023	TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..	CI
2023	An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.	CI

Mikrocoze Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2019

July 15, 2019 at 08:11 pm

Mikrocoze Inc. announced earnings results for the second quarter ended May 31, 2019. For the second quarter, the company announced net loss was USD 4,631 compared to USD 5,004 a year ago. For the half year, net loss was USD 13,826 compared to USD 16,237 a year ago.

Latest news about Instadose Pharma Corp.

TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp..	18/09/23	CI
An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million.	06/07/23	CI
Instadose Pharma Corp. Announces Board Changes	07/11/22	CI
Instadose Pharma Corp. Announces Resignation of Alex Wylie as Chief Financial Officer	07/11/22	CI
Instadose Pharma Corp. Announces CEO Changes	07/11/22	CI
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	09/05/22	CI
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	09/05/22	CI
Instadose Pharma Corp. Reports Earnings Results for the Full Year Ended November 30, 2021	15/03/22	CI
Instadose Pharma Corp. Announces Management Transition	14/01/22	CI
Instadose Pharma Corp. completed the acquisition of Mikrocoze Inc. in a reverse merger transaction.	30/12/21	CI
Instadose Pharma Corp. Establishes New Supply Route from South Africa to North Macedonia	25/10/21	CI
Instadose Pharma Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2021	13/10/21	CI
Instadose Pharma Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	14/07/21	CI
Instadose Pharma Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	14/04/21	CI
Mikrocoze Inc. Reports Earnings Results for the Full Year Ended November 30, 2020	25/02/21	CI
Instadose Pharma Corp. entered into a non-binding letter of intent to acquire Mikrocoze Inc. for $0.03 million in a reverse merger transaction.	06/12/20	CI
Mikrocoze Inc. Ceases Sukhmanjit Singh as Chief Executive Officer	06/11/20	CI
Mikrocoze Inc. Ceases Sukhmanjit Singh as Chief Financial Officer	06/11/20	CI
Mikrocoze Inc. Announces Executive Changes	06/11/20	CI
Mikrocoze Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2020	15/10/20	CI
Mikrocoze Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2020	20/07/20	CI
Mikrocoze Inc. Reports Earnings Results for the First Quarter Ended February 29, 2020	14/04/20	CI
Mikrocoze Inc. Reports Earnings Results for the Full Year Ended November 30, 2019	03/03/20	CI
Mikrocoze Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2019	11/10/19	CI
Mikrocoze Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2019	15/07/19	CI

Chart Instadose Pharma Corp.

Duration

Period

More charts

Company Profile

IDP Holdings (USA) Corp., formerly Instadose Pharma Corp. (Instadose Canada), is a holding company. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canadaâs Global Distribution Platform spans five continents, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies, and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents.

Sector

Home Furnishings

More about the company

Income Statement Evolution

More financial data

Sector Other Home Furnishings

	1st Jan change	Capi.
INSTADOSE PHARMA CORP.	-.--%	35
MAN WAH HOLDINGS LIMITED	+21.31%	3.22B
LEGGETT & PLATT, INCORPORATED	-52.94%	1.62B
ZIEL HOME FURNISHING TECHNOLOGY CO., LTD.	+4.52%	1.39B
LUOLAI LIFESTYLE TECHNOLOGY CO., LTD.	-5.38%	1.01B
SHANGHAI SHUIXING HOME TEXTILE CO., LTD.	+34.35%	701M
LOCTEK ERGONOMIC TECHNOLOGY CORP.	-10.94%	689M
DER FUTURE SCIENCE AND TECHNOLOGY HOLDING GROUP CO., LTD.	-30.28%	387M
ZHEJIANG ZHENGTE CO., LTD.	-10.75%	330M
DEXELANCE S.P.A.	+1.77%	303M

Other Home Furnishings

Instadose Pharma Corp.

Equities

INSD

US45783B1035

Home Furnishings

Mikrocoze Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2019

Latest news about Instadose Pharma Corp.

Chart Instadose Pharma Corp.

Company Profile

Income Statement Evolution

Sector Other Home Furnishings